FDA Approves First Medication to Help Reduce Allergic Reactions to Multiple Foods After Accidental Exposure

SILVER SPRING, Md., Feb. 16, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Xolair (omalizumab) injection for immunoglobulin E-mediated food allergy in certain adults and children 1 year or older for the reduction of allergic reactions (Type I), including…